Shri Ahimsa Naturals Ltd is set to launch its initial public offering (IPO) on March 25, 2025, aiming to raise approximately ₹73.81 crore. This IPO includes a fresh issue of 42,03,600 equity shares and an offer for sale (OFS) of 19,99,200 equity shares by promoters Nemi Chand Jain and Sumitra Jain.

Company Overview

Incorporated in 1990, Shri Ahimsa Naturals Limited specializes in extracting and manufacturing natural caffeine products, including Caffeine Anhydrous Natural, Green Coffee Bean Extracts (GCE), and Crude Caffeine. The company also trades various herbal extracts used across the food & beverage, nutraceuticals, cosmetics, and pharmaceutical industries. Operating as an Export Oriented Unit, it supplies products to over 14 countries, including the USA, Germany, South Korea, and the UK.

IPO Timeline

• Issue Open Date: March 25, 2025

• Issue Close Date: March 27, 2025​

• Allotment Finalization: March 28, 2025​

• Refund Initiation: April 1, 2025​

• Share Credit to Demat Accounts: April 1, 2025​

• Listing Date: April 2, 2025​

Note: These dates are tentative and subject to change. ​

Price Band and Lot Size

• Price Band: ₹113 to ₹119 per share​

• Lot Size: 1,200 shares​

• Minimum Investment: ₹1,42,800 (at the upper price band)​

Retail investors can apply for a minimum of one lot (1,200 shares), while High Net-worth Individuals (HNIs) need to bid for at least two lots (2,400 shares), amounting to ₹2,85,600.

Financials

In the financial year 2023-24, Shri Ahimsa Naturals reported a total income of ₹78.08 crore and a net profit of ₹18.67 crore. For the half-year ended September 30, 2024, the company recorded a net profit of ₹9.74 crore on a total income of ₹41.37 crore. ​

Strengths

• Experienced Management: Led by seasoned promoters with extensive industry knowledge.​

• Technological Capabilities: Advanced manufacturing processes and in-house R&D.​

• Quality Assurance: ISO-certified facilities ensuring high-quality products.​

• Customer Relationships: Established long-term client relationships.​

• Export Focus: Strong presence in international markets.​

Risks

• Project Execution: Potential delays or cost overruns in setting up new manufacturing facilities.

• Customer Concentration: Dependence on a few large customers for significant revenue.​

• Operational Risks: Operations concentrated in a single location, posing risks of disruption.​

• Supplier Dependence: Reliance on key suppliers for raw materials.​

• Regulatory Environment: Subject to changing health trends and regulations.​

IPO Anchor Investors Details

Specific details about anchor investors have not been disclosed as of now.​

IPO Promoter Holding Details

IPO Grey Market Premium (GMP)

Note: GMP is subject to market conditions and can fluctuate. ​

Final Thoughts

Shri Ahimsa Naturals Limited’s IPO offers investors an opportunity to participate in a company with a strong export focus and a diversified product portfolio in the natural extracts industry. Potential investors should consider the company’s financial performance, strengths, and associated risks before making investment decisions.​